QA: Altimmune Inc in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001326190_2013_Altimmune_Inc.pdf

Logs

warning The stock_price does not exist industry.us_generic {}

Graph

Absolute values for 0001326190, Altimmune Inc

  xvar xval
0 AssetsCurrent 19,795,845
1 IntangibleAssetsNetIncludingGoodwill 2,348,453
2 PropertyPlantAndEquipmentNet 483,976
3 remainder_Assets 113,130
4 LiabilitiesCurrent 7,488,416
5 LiabilitiesNoncurrent 2,283,535
6 remainder_Liabilities 1,295,613
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,628,732
9 ResearchAndDevelopmentExpense 19,509,629
10 remainder_Expenses 499,445
11 remainder_Revenues 0
12 remainder_NetIncome 26,717,691
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 22,741,404
1 Liabilities 11,067,564
2 Expenses 31,637,806
3 Revenues 0
4 StockholdersEquity 11,673,840
5 NetIncome -4,920,115
6 ComprehensiveNetIncome -4,920,115
7 BaseVar 46,082,232
8 EconomicCapitalRatiobeforeLimitedLiability 1.21
9 EconomicCapitalRatio 2.47

Edgar->Model Mapping

Feature Distribution

Change over Time